US Drug Recall Register
Class I · High risk Terminated Initiated Apr 13, 2017 (9 years ago)

Hyland's Baby Nighttime Teething Tablets

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.

What was recalled

Hyland's Baby Nighttime Teething Tablets [Belladonna 12X HPUS (0.0000000000003% alkaloids, calculated), Calcarea Phosphorica 6X HPUS, Chamomilla 6X HPUS, Coffea Cruda 6X HPUS, Magnesia Phosphorica 6X HPUS, Rheum 6X HPUS, Silicea 12X HPUS] Quick-Dissolving Tablets, 135-count bottle, Manufactured for: Hyland's, Inc., Los Angesles, CA 90061, NDC 54973-3197-1, UPC 3 54973 31971 4.

Recalling firm
Standard Homeopathic Company
NDC code
54973-3197-1
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0864-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Belladonna recalls

See all
Class I · High risk Terminated

Hyland's Baby Teething Tablets

Reason Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.

Standard Homeopathic Company NDC 54973-3127-3 D-0863-2017
Class II · Moderate risk Terminated

Belladonna Extract Powder active pharmaceutical ingredient…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-535-2015
Class II · Moderate risk Terminated

Belladonna Alkaloids with Phenobarbital Tablets

Reason Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets

West-Ward Pharmaceutical Corp. NDC 0143-1140-10 D-883-2013
Class II · Moderate risk Terminated

Belladonna Alkaloids/PB

Reason Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

Physicians Total Care, Inc. NDC 54868-0031-04 D-826-2013